HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Polli Selected Research

Time-to-Treatment

9/2000Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study.
4/2000Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Polli Research Topics

Disease

6Breast Neoplasms (Breast Cancer)
11/2006 - 04/2000
3Neoplasms (Cancer)
04/2016 - 04/2000
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Disease Progression
05/2000

Drug/Important Bio-Agent (IBA)

6exemestane (Aromasin)FDA Link
11/2006 - 04/2000
3TamoxifenFDA LinkGeneric
09/2000 - 04/2000
3Aromatase (CYP19)IBA
09/2000 - 04/2000
2CrizotinibIBA
01/2018 - 04/2016
2Aromatase InhibitorsIBA
11/2006 - 06/2000
2Megestrol Acetate (Borea)FDA LinkGeneric
09/2000 - 04/2000
1Anaplastic Lymphoma KinaseIBA
01/2018
1LipidsIBA
11/2006
1Hormones (Hormone)IBA
09/2000
1Acetates (Acetic Acid Esters)FDA Link
09/2000

Therapy/Procedure

2Time-to-Treatment
09/2000 - 04/2000
2Therapeutics
06/2000 - 05/2000
1Aftercare (After-Treatment)
06/2000
1Drug Therapy (Chemotherapy)
06/2000